Results 21 to 30 of about 76,100 (290)

Heterogeneity of Baló’s concentric sclerosis: a study of eight cases with different therapeutic concepts

open access: yesBMC Neurology, 2020
Background Baló’s Concentric Sclerosis (BCS) is a rare heterogeneous demyelinating disease with a variety of phenotypes on Magnetic Resonance Imaging (MRI).
D. Tzanetakos   +11 more
doaj   +1 more source

Electroneurophysiological criteria of efficiency of pathogenetic therapy in diabetic polyneuropathy. [PDF]

open access: yesĶazaķstannyṇ Klinikalyķ Medicinasy, 2016
Purpose: to estimate efficiency of pathogenetic therapy of diabetic polyneuropathy with including of benfotiaminby means of an electroneuromyography.
Lubov Kuzina, Gulnaz Kaishibayeva
doaj   +1 more source

The Role of Visual Evoked Potentials in the Differential Diagnosis of Demyelinating Diseases

open access: yesTürk Nöroloji Dergisi, 2021
Objective: Demyelinating diseases are included in the differential diagnosis of non-specific white matter lesions (NSWMLs), which are incidentally detected by magnetic resonance imaging (MRI) of the brain.
Nurhan Kaya Tutar   +4 more
doaj   +1 more source

The role of glial cells in neurodegenerative diseases. Part 2. Glial cells pathophysiology in neurodegeneration [PDF]

open access: yesFarmacja Polska, 2022
The proper operation of the nervous system is strongly dependent on the interactions between neurons and glial cells. Thus, the disturbance of their relationship leads to various neurological complications.
Mateusz Maszczyk   +2 more
doaj   +1 more source

Exogenous schwann cells migrate, remyelinate and promote clinical recovery in experimental auto-immune encephalomyelitis [PDF]

open access: yes, 2012
Schwann cell (SC) transplantation is currently being discussed as a strategy that may promote functional recovery in patients with multiple sclerosis (MS) and other inflammatory demyelinating diseases of the central nervous system (CNS).
Bachelin, Corinne   +9 more
core   +8 more sources

RESULTS OF AN OPEN-LABEL COMPARATIVE RANDOMIZED CLINICAL TRIAL OF AXOGLATIRAN® FS (F-SINTEZ, RUSSIA) EFFICIENCY AND SAFETY IN COMPARISON WITH COPAXONE®-TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD., ISRAEL) IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS

open access: yesНервно-мышечные болезни, 2017
Objective. Comparison of Axoglatiran® FS (F-Sintez,  Russia) and Copaxone®-Teva (Teva Pharmaceutical Industries Ltd.,  Israel) efficiency and safety in patients with relapsing-remitting multiple sclerosis. Materials and methods. In the study 150 patients
F. A. Khabirov   +5 more
doaj   +1 more source

Demyelination in rheumatic diseases [PDF]

open access: yesPostgraduate Medical Journal, 2008
Abstract Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) characterised by multifocal areas of demyelination in the white matter of the brain and spinal cord. Autoantibodies, for example antinuclear antibodies, can also be present.
A Theodoridou, Loukas Settas
openaire   +4 more sources

Psychiatric manifestations of multiple sclerosis and acute disseminated encephalomyelitis [PDF]

open access: yes, 2006
It is unusual for acute disseminated encephalomyelitis and multiple sclerosis to present as purely psychiatric disorders. We report five patients with such demyelinating diseases and symptoms of psychosis, depression or anxiety.
Brinar, Marko   +3 more
core   +1 more source

The role of glial cells in neurodegenerative diseases. Part 1. Characteristics and physiological functions [PDF]

open access: yesFarmacja Polska, 2022
The nervous system is composed of two dominant types of cells – neurons and glial cells. They differ from each other both morphologically and physiologically.
Mateusz Maszczyk   +2 more
doaj   +1 more source

Coincident onset of multiple sclerosis and herpes simplex virus 1 encephalitis. a case report [PDF]

open access: yes, 2017
Background: Along with vitamin D, smoking, body mass index and others, Epstein Barr virus, other herpesviruses and human endogenous retroviruses represent plausible environmental risk factors for multiple sclerosis.
Buscarinu, M. C.   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy